The company behind the test.

suPAR Bio was founded by Matt Wiggins, an American healthcare entrepreneur and investor.

suPAR Bio is the exclusive U.S. distributor of the suPARnostic® AUTO Flex ELISA from ViroGates A/S.

suPAR has 20+ years of research and 1,000+ peer-reviewed studies. The published suPAR research base is predominantly European.

Establishing a baseline while a patient is healthy provides a point of comparison for later suPAR results. No consensus clinical cutoffs have been established for chronic inflammation assessment in ambulatory or wellness populations.